1 / 13

Artificial Intelligence (AI) in Pharmaceutical Market Share, Size, Trends 2030

Artificial intelligence in pharmaceutics has grown over the years, and it can save money and effort while offering a greater knowledge of the interactions between different compositions and process parameters.

leeortega
Download Presentation

Artificial Intelligence (AI) in Pharmaceutical Market Share, Size, Trends 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Artificial Intelligence (AI) in Pharmaceutical Market Market Size Worth $4,206.1 Million By 2027 | CAGR: 41.01%

  2. Artificial Intelligence (AI) in Pharmaceutical Market Size worth $7,147.2 Million by 2029 | CAGR: 31.2% “As per Polaris Market Research report, Artificial Intelligence (AI) in Pharmaceutical market is attending major innovations & transformations and is projected to reach$7,147.2 Million by 2029 registering a CAGR of 31.2% during the conjecture period 2022 to 2029 The global Artificial Intelligence (AI) in Pharmaceutical market report scrutinizes the present situation and development prognosis of the market. The report offers a complete knowledge of key parameters such as market size, share and growth, trends, cost structure, and comprehensive and statistical data in the global Artificial Intelligence (AI) in Pharmaceutical market. Also, the market overview section of the report holds an in-depth analysis of current and future trends, analyzing the data on a historical basis and forecasted data till the year 2027. The report traces key market drivers, covering potentially lucrative opportunities and challenges as well as drivers, obstacles, issues, and risks. Artificial Intelligence (AI) in Pharmaceutical Market Report Scope: The global Artificial Intelligence (AI) in Pharmaceutical market is segmented by application, technology, offering, deployment, and region. The research report analyzes the most important trends related to the different segments that help to explain the market. The report additionally surveys both developed & developing regions considered for global Artificial Intelligence (AI) in Pharmaceutical market research. The regional analysis engages readers with a comprehensive overview of various countries and regions to help players plan effective expansion strategies. - 2 -

  3. Artificial Intelligence (AI) in Pharmaceutical Market Size worth $7,147.2 Million by 2029 | CAGR: 31.2% By Deployment By Application By Technology By Offering By Region  Drug Discovery  Machine  Hardware  Cloud  North America  Precision Medicine Learning  Software  On-Premises (U.S., Canada)  Medical Imaging &  Natural  Services  Europe (France, Diagnostics Language Germany, UK, Italy,  Research Processin Spain, g Netherlands,  Deep Austria) Learning  Asia Pacific  Others (Japan, China, India, Malaysia, Indonesia. South Korea)  Latin America (Brazil, Mexico, Argentina)  MEA (Saudi Arabia, UAE, Israel, South Africa) The report outlines the noteworthy factors, such as driving factors and challenges, that will explain the market’s future growth. Also, it covers an exhaustive coverage of major industry drivers, restraints, and their impact on global Artificial Intelligence (AI) in Pharmaceutical market growth during the forecast period from 2022-2030. The market research assists in studying the key plans, initiatives, and strategies for the development of the market. COVID-19 Impact Analysis for Artificial Intelligence (AI) in Pharmaceutical Market The market has also been affected by the recent COVID-19 pandemic and is expected to experience its long- term effects over the forecast period. Extensive evaluation of the effect of the COVID-19 pandemic is given to uncover the major issues and potential paths forward. The report merges the customer spending habits, business target, dynamics of current market forces, re-routing of the supply chain, and competitors in the - 3 -

  4. Artificial Intelligence (AI) in Pharmaceutical Market Size worth $7,147.2 Million by 2029 | CAGR: 31.2% global Artificial Intelligence (AI) in Pharmaceuticalmarket as a thorough analysis. The report serves overall estimation, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Artificial Intelligence (AI) in Pharmaceutical market across different regions and how major players are building strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities Regional Outlook In terms of geography, the region dominated the market with its higher revenue share contribution. The driving factors for this regional market growth include the current technological advancements in the industry, growing economic stability, huge government investments, and rising awareness related to the benefits of the product/service. Browse Detailed Research Report On Artificial Intelligence (AI) in Pharmaceutical Market Analysis: https://www.polarismarketresearch.com/industry-analysis/artificial-intelligence-ai-in- pharmaceutical-market Competitive Landscape The report completely profiles prominent market players or industrialists covering company profile, product specifications, production capacity/sales, revenue, price, and gross margin & sales. Here you will find a comprehensive analysis of the competitive landscape and detailed information on vendors and factors that will challenge the growth of major vendors. The section highlights key points such as regional segmentation, major investments, and details of historical, present, and projected revenues. the product portfolio, market explanation, and classification are indicated. According to Polaris Market Research, the leading players with a noteworthy dominance in the Artificial Intelligence (AI) in Pharmaceutical market include AstraZeneca LLC, Atomwise Inc., Bayer AG, Cloud Pharmaceuticals Inc, GNS Healthcare, IBM Watson, Merck & Co., Microsoft Corporation, Novartis AG, NVIDIA Corporation, Pfizer Inc., Recursion Pharmaceuticals Inc., and XtalPi Inc. Request for sample: https://www.polarismarketresearch.com/industry-analysis/artificial-intelligence-ai- in-pharmaceutical-market/request-for-sample Table of Contents 1. Introduction 1.1. Report Description 1.1.1. Objectives of the Study 1.1.2. Market Scope - 4 -

  5. Artificial Intelligence (AI) in Pharmaceutical Market Size worth $7,147.2 Million by 2029 | CAGR: 31.2% 1.1.3. Assumptions 1.2. Stakeholders 2. Executive Summary 2.1. Market Highlights 3. Research Methodology 3.1. Overview 3.1.1. Data Mining 3.2. Data Sources 3.2.1. Primary Sources 3.2.2. Secondary Sources 4. Global Artificial Intelligence (AI) in Pharmaceutical Market Insights 4.1. Artificial Intelligence (AI) in Pharmaceutical – Industry Snapshot 4.2. Artificial Intelligence (AI) in Pharmaceutical Market Dynamics 4.2.1. Drivers and Opportunities 4.2.1.1. High investment for the fruitful results 4.2.1.2. High failure rates in clinical trials 4.2.2. Restraints and Challenges 4.2.2.1. High cost of operation 4.3. Porter’s Five Forces Analysis 4.3.1. Bargaining Power of Suppliers (Moderate) 4.3.2. Threats of New Entrants: (Low) 4.3.3. Bargaining Power of Buyers (Moderate) 4.3.4. Threat of Substitute (Moderate) 4.3.5. Rivalry among existing firms (High) 4.4. PESTLE Analysis 4.5. Artificial Intelligence (AI) in Pharmaceutical Industry Trends 4.6. Value Chain Analysis 4.7. COVID-19 Impact Analysis 5. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Application 5.1. Key Findings 5.2. Introduction 5.2.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 5.3. Drug Discovery 5.3.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Drug Discovery, by Region, 2017 - 2029 (USD Million) 5.4. Precision Medicine 5.4.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Precision Medicine, by Region, 2017 - 2029 (USD Million) 5.5. Medical Imaging & Diagnostics 5.5.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Medical Imaging & Diagnostics, by Region, 2017 - 2029 (USD Million) 5.6. Research 5.6.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Research, by Region, 2017 - 2029 (USD Million) 6. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Technology 6.1. Key Findings 6.2. Introduction 6.2.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 6.3. Machine Learning - 5 -

  6. Artificial Intelligence (AI) in Pharmaceutical Market Size worth $7,147.2 Million by 2029 | CAGR: 31.2% 6.3.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Machine Learning, by Region, 2017 - 2029 (USD Million) 6.4. Natural Language Processing 6.4.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Natural Language Processing, by Region, 2017 - 2029 (USD Million) 6.5. Deep Learning 6.5.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Deep Learning, by Region, 2017 - 2029 (USD Million) 6.6. Others 6.6.1. Global Other Artificial Intelligence (AI) in Pharmaceutical Market, by Region, 2017 - 2029 (USD Million) 7. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Offering 7.1. Key Findings 7.2. Introduction 7.2.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 7.3. Hardware 7.3.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Hardware, by Region, 2017 - 2029 (USD Million) 7.4. Software 7.4.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Software, by Region, 2017 - 2029 (USD Million) 7.5. Services 7.5.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Services, by Region, 2017 - 2029 (USD Million) 8. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment 8.1. Key Findings 8.2. Introduction 8.2.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 8.3. Cloud 8.3.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Cloud, by Region, 2017 - 2029 (USD Million) 8.4. On-Premises 8.4.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by On-Premises, by Region, 2017 - 2029 (USD Million) 9. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Geography 9.1. Key findings 9.2. Introduction 9.2.1. Artificial Intelligence (AI) in Pharmaceutical Market Assessment, By Geography, 2017 - 2029 (USD Million) 9.3. Artificial Intelligence (AI) in Pharmaceutical Market – North America 9.3.1. North America: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.3.2. North America: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.3.3. North America: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.3.4. North America: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.3.5. Artificial Intelligence (AI) in Pharmaceutical Market – U.S. - 6 -

  7. Artificial Intelligence (AI) in Pharmaceutical Market Size worth $7,147.2 Million by 2029 | CAGR: 31.2% U.S.: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.3.5.2. U.S.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.3.5.3. U.S.: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.3.5.4. U.S.: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.3.6. Artificial Intelligence (AI) in Pharmaceutical Market – Canada 9.3.6.1. Canada: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.3.6.2. Canada: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.3.6.3. Canada: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.3.6.4. Canada: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.4. Artificial Intelligence (AI) in Pharmaceutical Market – Europe 9.4.1. Europe: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.4.2. Europe: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.4.3. Europe: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.4.4. Europe: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.4.5. Artificial Intelligence (AI) in Pharmaceutical Market – UK 9.4.5.1. UK: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.4.5.2. UK: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.4.5.3. UK: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.4.5.4. UK: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.4.6. Artificial Intelligence (AI) in Pharmaceutical Market – France 9.4.6.1. France: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.4.6.2. France: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.4.6.3. France: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.4.6.4. France: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.4.7. Artificial Intelligence (AI) in Pharmaceutical Market – Germany 9.4.7.1. Germany: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.4.7.2. Germany: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.4.7.3. Germany: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.3.5.1. - 7 -

  8. Artificial Intelligence (AI) in Pharmaceutical Market Size worth $7,147.2 Million by 2029 | CAGR: 31.2% Germany: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.4.8. Artificial Intelligence (AI) in Pharmaceutical Market – Italy 9.4.8.1. Italy: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.4.8.2. Italy: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.4.8.3. Italy: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.4.8.4. Italy: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.4.9. Artificial Intelligence (AI) in Pharmaceutical Market – Spain 9.4.9.1. Spain: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.4.9.2. Spain: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.4.9.3. Spain: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.4.9.4. Spain: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.4.10. Artificial Intelligence (AI) in Pharmaceutical Market – Netherlands 9.4.10.1. Netherlands: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.4.10.2. Netherlands: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.4.10.3. Netherlands: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.4.10.4. Netherlands: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.4.11. Artificial Intelligence (AI) in Pharmaceutical Market – Austria 9.4.11.1. Austria: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.4.11.2. Austria.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.4.11.3. Austria: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.4.11.4. Austria: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.5. Artificial Intelligence (AI) in Pharmaceutical Market – Asia Pacific 9.5.1. Asia Pacific: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.5.2. Asia Pacific: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.5.3. Asia Pacific: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.5.4. Asia Pacific: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.5.5. Artificial Intelligence (AI) in Pharmaceutical Market – China 9.5.5.1. China: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.5.5.2. China.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.4.7.4. - 8 -

  9. Artificial Intelligence (AI) in Pharmaceutical Market Size worth $7,147.2 Million by 2029 | CAGR: 31.2% China: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.5.5.4. China: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.5.6. Artificial Intelligence (AI) in Pharmaceutical Market – India 9.5.6.1. India: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.5.6.2. India.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.5.6.3. India: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.5.6.4. India: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.5.7. Artificial Intelligence (AI) in Pharmaceutical Market – Japan 9.5.7.1. Japan: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.5.7.2. Japan.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.5.7.3. Japan: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.5.7.4. Japan: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.5.8. Artificial Intelligence (AI) in Pharmaceutical Market – Malaysia 9.5.8.1. Malaysia: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.5.8.2. Malaysia.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.5.8.3. Malaysia: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.5.8.4. Malaysia: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.5.9. Artificial Intelligence (AI) in Pharmaceutical Market – Indonesia 9.5.9.1. Indonesia: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.5.9.2. Indonesia.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.5.9.3. Indonesia: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.5.9.4. Indonesia: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.5.10. Artificial Intelligence (AI) in Pharmaceutical Market – South Korea 9.5.10.1. South Korea: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.5.10.2. South Korea.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.5.10.3. South Korea: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.5.10.4. South Korea: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.6. Artificial Intelligence (AI) in Pharmaceutical Market – Middle East & Africa 9.6.1. Middle East & Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.5.5.3. - 9 -

  10. Artificial Intelligence (AI) in Pharmaceutical Market Size worth $7,147.2 Million by 2029 | CAGR: 31.2% 9.6.2. Middle East & Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.6.3. Middle East & Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.6.4. Middle East & Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.6.5. Artificial Intelligence (AI) in Pharmaceutical Market – Saudi Arabia 9.6.5.1. Saudi Arabia: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.6.5.2. Saudi Arabia: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.6.5.3. Saudi Arabia: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.6.5.4. Saudi Arabia: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.6.6. Artificial Intelligence (AI) in Pharmaceutical Market – South Africa 9.6.6.1. South Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.6.6.2. South Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.6.6.3. South Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.6.6.4. South Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.6.7. Artificial Intelligence (AI) in Pharmaceutical Market – Israel 9.6.7.1. Israel: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.6.7.2. Israel: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.6.7.3. Israel: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.6.7.4. Israel: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.6.8. Artificial Intelligence (AI) in Pharmaceutical Market – UAE 9.6.8.1. UAE: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.6.8.2. UAE: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.6.8.3. UAE: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.6.8.4. UAE: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.7. Artificial Intelligence (AI) in Pharmaceutical Market – Latin America 9.7.1. Latin America: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.7.2. Latin America: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.7.3. Latin America: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.7.4. Latin America: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.7.5. Artificial Intelligence (AI) in Pharmaceutical Market – Mexico - 10 -

  11. Artificial Intelligence (AI) in Pharmaceutical Market Size worth $7,147.2 Million by 2029 | CAGR: 31.2% Mexico: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.7.5.2. Mexico: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.7.5.3. Mexico: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.7.5.4. Mexico: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.7.6. Artificial Intelligence (AI) in Pharmaceutical Market – Brazil 9.7.6.1. Brazil: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.7.6.2. Brazil: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.7.6.3. Brazil: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.7.6.4. Brazil: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 9.7.7. Artificial Intelligence (AI) in Pharmaceutical Market – Argentina 9.7.7.1. Argentina: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million) 9.7.7.2. Argentina: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million) 9.7.7.3. Argentina: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million) 9.7.7.4. Argentina: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million) 10. Competitive Landscape 10.1. Expansion and Acquisition Analysis 10.1.1. Expansion 10.1.2. Acquisitions 10.2. Partnerships/Collaborations/Agreements/Exhibitions 11. Company Profiles 11.1. AstraZeneca LLC 11.1.1. Company Overview 11.1.2. Financial Performance 11.1.3. Product Benchmarking 11.1.4. Recent Development 11.2. Atomwise Inc. 11.2.1. Company Overview 11.2.2. Financial Performance 11.2.3. Product Benchmarking 11.2.4. Recent Development 11.3. Bayer AG 11.3.1. Company Overview 11.3.2. Financial Performance 11.3.3. Product Benchmarking 11.3.4. Recent Development 11.4. Cloud Pharmaceuticals Inc 11.4.1. Company Overview 11.4.2. Financial Performance 11.4.3. Product Benchmarking 11.4.4. Recent Development 9.7.5.1. - 11 -

  12. Artificial Intelligence (AI) in Pharmaceutical Market Size worth $7,147.2 Million by 2029 | CAGR: 31.2% 11.5. GNS Healthcare 11.5.1. Company Overview 11.5.2. Financial Performance 11.5.3. Product Benchmarking 11.5.4. Recent Development 11.6. IBM Watson 11.6.1. Company Overview 11.6.2. Financial Performance 11.6.3. Product Benchmarking 11.6.4. Recent Development 11.7. Merck & Co. 11.7.1. Company Overview 11.7.2. Financial Performance 11.7.3. Product Benchmarking 11.7.4. Recent Development 11.8. Microsoft Corporation 11.8.1. Company Overview 11.8.2. Financial Performance 11.8.3. Product Benchmarking 11.8.4. Recent Development 11.9. Novartis AG 11.9.1. Company Overview 11.9.2. Financial Performance 11.9.3. Product Benchmarking 11.9.4. Recent Development 11.10. NVIDIA Corporation 11.10.1. 11.10.2. 11.10.3. 11.10.4. 11.11. Pfizer Inc. 11.11.1. 11.11.2. 11.11.3. 11.11.4. 11.12. Recursion Pharmaceuticals Inc. 11.12.1. Company Overview 11.12.2. Financial Performance 11.12.3. Product Benchmarking 11.12.4. Recent Development 11.13. XtalPi Inc. 11.13.1. Company Overview 11.13.2. Financial Performance 11.13.3. Product Benchmarking 11.13.4. Recent Development Company Overview Financial Performance Product Benchmarking Recent Development Company Overview Financial Performance Product Benchmarking Recent Development  Access Press Release on Artificial Intelligence (AI) in Pharmaceutical Market: https://www.polarismarketresearch.com/press-releases/artificial-intelligence-ai-in- pharmaceutical-market  About Polaris Market Research - 12 -

  13. Artificial Intelligence (AI) in Pharmaceutical Market Size worth $7,147.2 Million by 2029 | CAGR: 31.2% Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 13 -

More Related